S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
NASDAQ:THAR

Tharimmune (THAR) Stock Price, News & Analysis

$0.38
-0.03 (-7.24%)
(As of 04/12/2024 ET)
Today's Range
$0.38
$0.42
50-Day Range
$0.36
$0.47
52-Week Range
$0.34
$32.75
Volume
305,377 shs
Average Volume
525,626 shs
Market Capitalization
$4.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
THAR stock logo

About Tharimmune Stock (NASDAQ:THAR)

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

THAR Stock Price History

THAR Stock News Headlines

This tech is sneaking up on Americans’ portfolios
Most Americans have zero idea how advanced A.I. has gotten. To them, it’s still a simple little chatbot that works like a really good version of Google. What they don’t realize is that it is becoming the go-to competitive advantage for people who are serious about their financial well-being. Whether it’s improving productivity at work, replacing employees in their business… or outperforming in the markets. A.I. grants the competitive advantage necessary to get ahead in this economy. It’s become the digital edge that can deliver solid returns… consistently.
This tech is sneaking up on Americans’ portfolios
Most Americans have zero idea how advanced A.I. has gotten. To them, it’s still a simple little chatbot that works like a really good version of Google. What they don’t realize is that it is becoming the go-to competitive advantage for people who are serious about their financial well-being. Whether it’s improving productivity at work, replacing employees in their business… or outperforming in the markets. A.I. grants the competitive advantage necessary to get ahead in this economy. It’s become the digital edge that can deliver solid returns… consistently.
Crude Oil Surges 2%; Tharimmune Shares Plummet
Why Is Tharimmune (THAR) Stock Down 70% Today?
Why Is Tharimmune (THAR) Stock Up 113% Today?
See More Headlines
Receive THAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/12/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:THAR
Previous Symbol
NASDAQ:THAR
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-9,320,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$13.03 per share

Miscellaneous

Free Float
11,462,000
Market Cap
$4.54 million
Optionable
Not Optionable
Beta
1.63
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

THAR Stock Analysis - Frequently Asked Questions

How have THAR shares performed in 2024?

Tharimmune's stock was trading at $0.5090 on January 1st, 2024. Since then, THAR stock has decreased by 24.4% and is now trading at $0.3846.
View the best growth stocks for 2024 here
.

Are investors shorting Tharimmune?

Tharimmune saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 75,300 shares, an increase of 230.3% from the March 15th total of 22,800 shares. Based on an average daily volume of 521,800 shares, the short-interest ratio is currently 0.1 days. Currently, 0.7% of the shares of the stock are sold short.
View Tharimmune's Short Interest
.

When is Tharimmune's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our THAR earnings forecast
.

When did Tharimmune's stock split?

Tharimmune shares reverse split on the morning of Tuesday, November 21st 2023. The 1-25 reverse split was announced on Tuesday, November 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Tharimmune?

Shares of THAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:THAR) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners